SEC Form 4 · accession 0001213900-17-006529
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandesh Seth
Officer — Chairman and CEO · Director
Period of report
Jun 15, 2017
Accepted (ET)
Jun 15, 2017 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jun 15, 2017 | P | 2,500 | $1.17 | A | 37,500 | D | |
| Common Stock | Jun 15, 2017 | P | 5,000 | $1.16 | A | 42,500 | D |
Table II — derivative securities
No Table II lines on this filing.